Ariad (ARIA) Stock | Will It Continue To Climb?
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) Ariad Pharmaceuticals stock climbed yesterday following the company’s announcement of preclinical data from 2 studies at the American Association for Cancer Research Annual Meeting 2015. The data was provided through two different presentations… ARIA Preclinical Data Presentations Oral Presentation on Brigatnib Discovery This demonstration described the design and chemical structure … Read more